Incidence of breast cancer in a cohort of 5,135 transgender veterans

Breast Cancer Research and Treatment

Volumn 149, Issue 1, 2015, Pages 191-198

  Brown, George R ^a,c,d   Jones, Kenneth T ^b  

^a James H Quillen VA Medical Center   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Breast; Cancer; Gender dysphoria; Gender identity; Hormones; Transgender; Veteran

Indexed keywords

SEX HORMONE;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER STAGING; CROSS SEX HORMONE TREATMENT; DISEASE SEVERITY; DRUG EXPOSURE; EUROPEAN; FEMALE; FEMALE TO MALE TRANSGENDER; GENDER DYSPHORIA; HORMONAL THERAPY; HUMAN; MALE; MALE TO FEMALE TRANSGENDER; MIDDLE AGED; NATAL MALE; NORTH AMERICAN; PRIORITY JOURNAL; RACE DIFFERENCE; TRANSGENDER; TRANSVESTIC FETISHISM; UNITED STATES; VETERAN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; ETHNIC GROUP; GENETICS; INCIDENCE; PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; ETHNIC GROUPS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; TRANSGENDERED PERSONS; UNITED STATES;

EID: 84922105963     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3213-2     Document Type: Article

References (46)

1. Benjamin H (1964) Clinical aspects of transsexualism in the male and female. Am J Psychother 18:458–469
2. Benjamin H (1966) The transsexual phenomena. Julian Press, New York
3. Symmers WC (1968) Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 2:83–85
4. Dhand A, Dhaliwal G (2010) Examining patient conceptions: a case of metastatic breast cancer in an African American male to female transgender patient. J Gen Intern Med 25:158–161
5. Nikolic DV, Djordjevic ML, Granic M, Nikolic AT, Stanimirovic VV, Zdravkovic D, Jelic S (2012) Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol 1:280
6. Shao T, Grossbard ML, Klein P (2011) Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer 11:417–419
7. Gooren L (2011) Care of transsexual persons. N Engl J Med 364:1251–1257
8. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635–642
9. Gooren LJ, van Trotsenburg MA, Giltay EJ, van Diest PJ (2013) Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med 12:3129–3134. doi:10.1111/jsm.12319
10. van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 47:337–342
11. Wierckx K, Mueller S, Weyers S et al (2012) Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 9:2641–2651
12. U.S. Department of Veterans Affairs. National Center for Veterans Analysis and Statistics (2013) Trends in the utilization of VA programs and services
13. U.S. Veterans Affairs, Veterans Health Administration: VHA Directive 2011–026: Providing Health Care for Transgender and Intersex Veterans (2011). http://www.va.gov/vhapublications Accessed on 12 May 2014
14. U.S. Veterans Affairs, Veterans Health Administration: VHA Directive 2013-003: Providing Health Care for Transgender and Intersex Veterans (2013). http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2863. Accessed on 12 May 2014
15. Lamoreaux J (1996) The organizational structure for medical information management in the Department of Veterans Affairs: an overview of major health care databases. Med Care 34(suppl):31–44
16. West AN, Lee RE, Shambaugh-Miller MD, Blair BD, Mueller KJ, Lilly RS, Kaboli PJ, Hawthorne K (2010) Defining “rural” for veterans’ health care planning. J Rural Health 26:301–309
17. VA Information Resource Center: Vital Status File Date of Birth (DOB) and Sex Quality Review. Hines, IL: U.S. Dept. of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center. http://www.virec.research.va.gov/Reports/DI/DI-VSF-DOB-SEX-Sept-CY11-ER.pdf Accessed on 2 June 2014
18. World Health Organisation International Statistical Classification of Diseases and Related Health Problems, 9th Revision (ICD-9-CM) (1978) Geneva
19. Surveillance, epidemiology, and end results program, SEER incidence rates and U.S. Death Rates, Age-Adjusted and Age-Specific Rates, by Race and Sex (Breast) (2014). Washington, DC. National Cancer Institute. Accessed on 24 June 2014
20. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2010 National Cancer Institute: Bethesda, MD. http://seer.cancer.gov/csr/1975_2010/browse_csr.php?section=4&page=sect_04_table.18.html, based on November 2012 SEER data submission, posted to the SEER Web site, April 2013. Accessed on 9 July 2014
21. R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
22. Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S, Adler RK, Brown GR, Devor AH, Ehrbar R, Ettner R, Eyler E, Garofalo R, Karasic DH, Lev AI, Mayer G, Meyer-Bahlburg H, Hall BP, Pfaefflin F, Rachlin K, Robinson B, Schechter LS, Tangpricha V, van Trotsenburg M, Vitale A, Winter S, Whittle S, Wylie KR, Zucker K (2012) Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. Int J Transgenderism 13:165–232
23. Makadon HJ, Mayer KH, Potter J (2007) Fenway guide to lesbian, gay, bisexual and transgender health, 1st ed. American College of Physicians, Philadelphia, PA, pp 3–22(35–36):331–392
24. Burcombe RJ, Makris A, Pittam M, Finer N (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast 12:290–293
25. Gethins M (2012) Breast cancer in men. J Natl Cancer Inst 104:436–438
26. Giordano S, Buzdar A, Hortobagyi G (2002) Breast cancer in men. Annals Intern Med 137:678–687
27. American Cancer Society. Cancer facts and figures (2014). American Cancer Society, Atlanta
28. Thomas DB (1993) Breast cancer in men. Epidemiol Rev 15:220–231
29. Guenel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, Baumgardt-Elms C, Menegoz F, Olsson H, Paulsen S, Simonato L, Wingren G (2004) Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 15:571–580
30. Collaborative group on Hormonal Factors in Breast Cancer (2002) Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87:1234–1245
31. Hedlund PO (2000) Side effects of endocrine treatment and their mechanisms: castration, antiandrogens, and estrogens. Prostate Suppl 10:32–37
32. Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F (2010) Risk of breast cancer in male BRCA2 carriers. J Med Genet 47:710–711
33. Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99:1811–1814
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Koopersberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 288:321–333
35. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rate by age and tumor characteristics among U.S. women. Breast Cancer Res 9:R28
36. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670–1674
37. Mepham N, Bouman W, Arcelus J, Hayter M, Wylie K (2014) People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge. J Sex Med. doi:10.1111/jsm.12691
38. Burgess H, Shousha S (1993) An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J Pathol 170:37–43
39. Shufelt CL, Braunstein GD (2008) Testosterone and the breast. Menopause Inter 14:117–122
40. Vujović S, Popović S, Milošević-Sbutega G, Đorđević M, Gooren LJG (2009) Transsexualism in Serbia: a twenty-year follow-up study. J Sex Med 6:1018–1023
41. Xavier JM, Bobbin M, Singer B, Budd E (2005) A needs assessment of transgendered people of color living in Washington, DC. Int J Transgenderism 8:31–47
42. Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 52:678–701
43. Deutsche M, Green J, Keatley J, Mayer G, Hastings J, Hall A (2013) Electronic medical records and the transgender patient: recommendations from the World Professional Association for Transgender Health EMR working group. J Am Med Inform Assoc 20:700–703
44. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ III, Spack NP, Tangpricha V, Montori VM (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154
45. Delemarre-van de Waal H, Cohen-Kettenis P (2006) Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol 155:S131–S137
46. Gooren LJ, Giltay EJ, Bunck MC (2008) Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93:19–25